MeSH term
Frequency | Condition_Probility | Cell Differentiation | 2 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Down-Regulation | 2 | 0.0 |
Humans | 113 | 0.0 |
Research Support, Non-U.S. Gov't | 79 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 6 | 0.0 |
Up-Regulation | 3 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 40 | 0.0 |
Transfection | 13 | 0.0 |
Amino Acid Sequence | 26 | 0.0 |
Animals | 64 | 0.0 |
Chromosome Mapping | 7 | 0.0 |
Cloning, Molecular | 13 | 0.0 |
Expressed Sequence Tags | 2 | 0.0 |
Gene Expression Profiling | 2 | 0.0 |
*Intracellular Signaling Peptides and Proteins | 7 | 0.0 |
Molecular Sequence Data | 40 | 0.0 |
Phosphorylation | 6 | 0.0 |
Phosphotyrosine/metabolism | 2 | 0.0 |
Protein Binding | 4 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Sequence Homology, Amino Acid | 13 | 0.0 |
Signal Transduction | 11 | 0.0 |
Tumor Cells, Cultured | 14 | 0.0 |
Cell Line, Transformed | 4 | 0.0 |
Cell Separation | 2 | 0.0 |
Female | 19 | 0.0 |
Lymphocyte Activation | 11 | 0.0 |
Middle Aged | 11 | 0.0 |
Cell Line | 24 | 0.0 |
Antibodies, Blocking/pharmacology | 2 | 2.0 |
Cell Line, Tumor | 2 | 0.0 |
Cells, Cultured | 18 | 0.0 |
Cytotoxicity Tests, Immunologic | 2 | 0.0 |
Killer Cells, Natural/*immunology/metabolism | 2 | 5.0 |
*Lymphocyte Activation/genetics | 2 | 7.0 |
Mice | 41 | 0.0 |
Mice, Inbred C57BL | 10 | 0.0 |
Mice, Knockout | 4 | 0.0 |
RNA, Messenger/biosynthesis | 3 | 0.0 |
Antigen Presentation | 2 | 0.0 |
Antigens, CD/analysis | 6 | 0.0 |
Comparative Study | 8 | 0.0 |
Immunophenotyping | 14 | 0.0 |
Lymphocyte Culture Test, Mixed | 4 | 0.0 |
Immunoglobulins/*genetics | 2 | 4.0 |
Killer Cells, Natural/*immunology | 13 | 2.0 |
T-Lymphocytes/*immunology | 11 | 0.0 |
Administration, Oral | 2 | 0.0 |
CD8-Positive T-Lymphocytes/immunology | 2 | 0.0 |
Histocompatibility Antigens Class I/immunology | 3 | 2.0 |
Mice, Transgenic | 3 | 0.0 |
Vaccines, DNA/administration & dosage/*immunology | 2 | 28.0 |
*Antigens, CD | 12 | 1.0 |
Gene Expression | 7 | 0.0 |
Glycosylation | 7 | 0.0 |
Leukocytes/immunology | 2 | 1.0 |
Multigene Family | 3 | 0.0 |
Mutation | 4 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Receptors, Immunologic/chemistry/genetics/*metabolism | 2 | 25.0 |
Drug Synergism | 2 | 0.0 |
Interferon Type II/secretion | 2 | 1.0 |
Lymphocyte Activation/immunology | 5 | 0.0 |
Membrane Glycoproteins/immunology | 5 | 2.0 |
Antigens, CD/*genetics | 9 | 3.0 |
Base Sequence | 28 | 0.0 |
Carrier Proteins/genetics | 2 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Membrane Glycoproteins/genetics | 4 | 2.0 |
RNA, Messenger | 4 | 0.0 |
*Receptors, Immunologic | 7 | 4.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Cell Adhesion Molecules/physiology | 2 | 2.0 |
K562 Cells | 3 | 0.0 |
English Abstract | 2 | 0.0 |
Intercellular Adhesion Molecule-1/metabolism | 2 | 1.0 |
Membrane Glycoproteins/metabolism | 4 | 0.0 |
T-Lymphocytes, Cytotoxic/immunology | 3 | 0.0 |
Antigens, CD/immunology | 6 | 1.0 |
Cell Membrane/metabolism | 3 | 0.0 |
Adult | 14 | 0.0 |
Blotting, Northern | 4 | 0.0 |
Flow Cytometry | 17 | 0.0 |
Gene Library | 4 | 0.0 |
*Membrane Glycoproteins | 2 | 0.0 |
Tissue Distribution | 3 | 0.0 |
Membrane Glycoproteins/*genetics/immunology | 2 | 10.0 |
RNA, Messenger/genetics | 3 | 0.0 |
Rats | 13 | 0.0 |
Receptors, Immunologic/*genetics/immunology | 2 | 15.0 |
Species Specificity | 2 | 0.0 |
Antigen-Presenting Cells/immunology | 2 | 0.0 |
Ligands | 20 | 0.0 |
Lymphocyte Activation/*immunology | 3 | 0.0 |
Membrane Glycoproteins/*immunology | 2 | 1.0 |
DNA, Complementary | 6 | 0.0 |
Male | 19 | 0.0 |
Mice, Inbred BALB C | 11 | 0.0 |
COS Cells | 4 | 0.0 |
Jurkat Cells | 6 | 0.0 |
Killer Cells, Natural/*metabolism | 2 | 3.0 |
Membrane Glycoproteins/*metabolism | 2 | 0.0 |
Mice, SCID | 2 | 0.0 |
T-Lymphocytes/*metabolism | 4 | 1.0 |
Leukocytes/*immunology | 3 | 2.0 |
Aged | 7 | 0.0 |
Antigens, CD/blood | 2 | 0.0 |
Antigens, CD55/blood | 2 | 25.0 |
Glycosylphosphatidylinositols/*blood | 3 | 42.0 |
Child, Preschool | 5 | 0.0 |
*Signal Transduction | 5 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Solubility | 5 | 0.0 |
Antigens, CD/*immunology | 8 | 1.0 |
*Adhesins, Escherichia coli | 2 | 40.0 |
Antigens, CD/metabolism | 6 | 0.0 |
*Fimbriae Proteins | 2 | 13.0 |
Opsonins/metabolism | 2 | 8.0 |
Phagocytosis | 2 | 0.0 |
*Lymphocyte Activation | 7 | 0.0 |
Receptors, Immunologic/*immunology | 4 | 3.0 |
Antigens, CD/*metabolism | 7 | 1.0 |
Cytokines/biosynthesis | 2 | 0.0 |
Cytotoxicity, Immunologic | 5 | 0.0 |
Tyrosine/metabolism | 3 | 0.0 |
Carbohydrate Conformation | 3 | 2.0 |
Carbohydrate Sequence | 4 | 1.0 |
Protein Conformation | 7 | 0.0 |
T-Lymphocytes/cytology/*immunology/*metabolism | 2 | 16.0 |
DNA, Complementary/genetics | 3 | 0.0 |
Introns | 2 | 0.0 |
Antibodies, Monoclonal/immunology | 7 | 0.0 |
Cytotoxicity, Immunologic/immunology | 2 | 2.0 |
Immunoglobulins/*immunology | 2 | 7.0 |
Cell Division/drug effects | 2 | 0.0 |
CHO Cells | 6 | 0.0 |
Hamsters | 9 | 0.0 |
*Membrane Proteins | 2 | 0.0 |
Protein Structure, Secondary | 2 | 0.0 |
*Receptors, Lipoprotein | 2 | 1.0 |
Recombinant Proteins/chemistry/metabolism | 3 | 0.0 |
Cell Division/immunology | 2 | 0.0 |
T-Lymphocytes/immunology | 4 | 0.0 |
Antigens, CD2 | 12 | 2.0 |
Adolescent | 8 | 0.0 |
Child | 6 | 0.0 |
Infant | 2 | 0.0 |
Antigens, CD2/metabolism | 3 | 10.0 |
Protein Binding/genetics/immunology | 2 | 2.0 |
Staining and Labeling | 2 | 0.0 |
T-Lymphocytes, Cytotoxic/immunology/metabolism | 2 | 14.0 |
Antibodies, Monoclonal | 13 | 0.0 |
In Vitro | 3 | 0.0 |
Binding Sites | 7 | 0.0 |
Detergents | 2 | 1.0 |
Enzyme-Linked Immunosorbent Assay | 2 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Receptors, IgE/biosynthesis | 2 | 9.0 |
Bone Marrow Transplantation/*immunology | 2 | 1.0 |
Binding, Competitive | 4 | 0.0 |
Cell Adhesion | 7 | 0.0 |
Cell Membrane/*metabolism | 2 | 0.0 |
Treatment Outcome | 2 | 0.0 |
Glycosylphosphatidylinositols/*metabolism | 3 | 5.0 |
Recombinant Proteins/metabolism | 4 | 0.0 |
Antibodies, Monoclonal/pharmacology | 3 | 0.0 |
Antigens, CD2/*metabolism | 2 | 6.0 |
Rats, Inbred Lew | 2 | 0.0 |
Receptors, Immunologic/*metabolism | 6 | 3.0 |
Time Factors | 3 | 0.0 |
Transplantation, Homologous | 2 | 0.0 |
Mice, Inbred CBA | 2 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
Calcium/metabolism | 3 | 0.0 |
Cell Adhesion/drug effects | 3 | 0.0 |
Antibodies, Monoclonal/chemistry/pharmacology | 2 | 40.0 |
Cell Adhesion/immunology | 4 | 2.0 |
*Apoptosis | 2 | 0.0 |
Chromosomes, Human, Pair 1 | 2 | 0.0 |
Glycosylphosphatidylinositols/*physiology | 3 | 20.0 |
Antibodies, Monoclonal/*immunology | 2 | 0.0 |
Kinetics | 3 | 0.0 |
Antigens, CD/biosynthesis/genetics | 2 | 5.0 |
Tumor Necrosis Factor-alpha/pharmacology | 2 | 0.0 |
Antigens, CD/immunology/*metabolism | 3 | 6.0 |
Blotting, Western | 2 | 0.0 |
Precipitin Tests | 2 | 0.0 |
Antigens, CD/*chemistry | 2 | 7.0 |
Binding, Competitive/immunology | 2 | 2.0 |
Structure-Activity Relationship | 3 | 0.0 |
Cell Communication/*immunology | 2 | 4.0 |
Antigens, CD/*physiology | 4 | 1.0 |
Antigens, CD2/*physiology | 2 | 8.0 |
Antigens, Ly/*genetics | 2 | 20.0 |
T-Lymphocytes/immunology/metabolism | 2 | 1.0 |
Antigens, CD59 | 6 | 3.0 |
Immunosuppression | 2 | 1.0 |
Erythrocytes/chemistry | 2 | 4.0 |
Mice, Inbred C3H | 3 | 0.0 |
Antigens, CD58 | 5 | 3.0 |
Antigens, Differentiation, T-Lymphocyte/*immunology | 3 | 1.0 |
Recombinant Proteins/immunology | 2 | 0.0 |
Protein Folding | 2 | 0.0 |
Hemoglobinuria, Paroxysmal/*blood | 2 | 7.0 |
Membrane Proteins/*physiology | 3 | 2.0 |
Lymphocytes/immunology | 4 | 1.0 |
Genetic Vectors | 2 | 0.0 |
Antigens, CD8/analysis | 2 | 0.0 |
Antigens, CD/*analysis | 2 | 0.0 |
B-Lymphocytes/immunology | 2 | 0.0 |
Antigens, Differentiation, T-Lymphocyte/*metabolism | 4 | 3.0 |
Epitopes | 2 | 0.0 |
Models, Molecular | 3 | 0.0 |
Oligodeoxyribonucleotides | 2 | 0.0 |
DNA/genetics | 2 | 0.0 |
Restriction Mapping | 2 | 0.0 |
Antigens, CD55 | 2 | 1.0 |
Herpesvirus 4, Human | 2 | 1.0 |
*Lymphocyte Depletion | 2 | 2.0 |
Membrane Glycoproteins/physiology | 2 | 1.0 |
Glycosylphosphatidylinositols | 4 | 7.0 |
Graft Rejection | 2 | 1.0 |
Reproducibility of Results | 2 | 0.0 |
